About
Dr Emily Colvin is a Research Fellow at the School of Medical Sciences, University of Sydney, affiliated with the Faculty of Medicine and Health. Her research focuses on cancer biology, particularly ovarian and pancreatic cancers, with a focus on biomarkers, tumor microenvironment dynamics, and preclinical therapeutic modeling. She has contributed to studies on plant cannabinoids in mesothelioma, nanoparticle biodistribution in cancer imaging, and predictive biomarkers for pancreatic cancer outcomes.
Research Interests:
- Development of mouse models for cancer research
- Role of tumor-associated fibroblasts and macrophages in cancer progression
- Biomarker identification for personalized cancer therapy
- Preclinical evaluation of novel anti-cancer agents
Key Grants:
- Cancer Institute NSW Early Career Fellowship (2016)
- National Health and Medical Research Council Clinical Trials Support (2021)
- Fight for a Cure Research Grant (2019)
Recent Research Trends:
Her work spans translational cancer research, with recent emphasis on:
- Immunological biomarkers (e.g., NLR, PLR)
- Targeting cancer-associated fibroblasts
- Epigenetic therapy for pancreatic cancer
Awards:
- Cancer Institute NSW Early Career Fellowship (2016)
Labs/Teams:
Collaborates with the Translational Cancer Research Facility and teams at the Sydney Medical School.
0Publications listed
Find Emily Colvin elsewhere
Related Searches
You Might Also Like
- DDavid ChanUniversity of Sydney · Senior Lecturer
- AAmanda HudsonUniversity of Sydney · Research Fellow
Haiyong HanBeckman Research Institute of City of Hope · Professor- SSumit SahniUniversity of Sydney · Adjunct Associate Professor
Tracy HoangThe University of Western Australia · Research Fellow
Bahil Darson GhanimParis Lodron University of Salzburg · Associate Clinical Professor